» Authors » Shaopeng Qiu

Shaopeng Qiu

Explore the profile of Shaopeng Qiu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 447
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gong M, Feng S, Zhou D, Luo J, Lin T, Qiu S, et al.
Eur J Med Res . 2023 Oct; 28(1):440. PMID: 37848987
Background: Renal cell carcinoma (RCC) accounts for approximately 2-3% of all adult malignancies. Clear cell renal cell carcinoma (ccRCC), which comprises 70-80% of all RCC cases, is the most common...
2.
Gong M, Li Y, Song E, Li M, Qiu S, Dong W, et al.
Front Immunol . 2022 Mar; 13:805552. PMID: 35242130
Opa interacting protein 5 (), overexpressed in some types of human cancers, has been reported to be associated with the carcinogenesis of human cancer. However, its contribution to cancer immunity...
3.
Jiang S, Yang Y, Mo C, Chen L, Qiu S, Huang B, et al.
J Int Med Res . 2019 Aug; 47(11):5802-5808. PMID: 31452410
No abstract available.
4.
Lin H, Hong Y, Huang B, Liu X, Zheng J, Qiu S
Biomed Res Int . 2019 Aug; 2019:7259691. PMID: 31428643
Vasculogenic mimicry (VM), the novel approach for tumor cells to obtain blood supply, was reported to be involved in antiangiogenic resistance and poor prognosis in renal cell carcinoma (RCC). However,...
5.
Yuan L, Huang X, Zhou K, Zhu X, Huang B, Qiu S, et al.
Prostate . 2019 Mar; 79(8):826-839. PMID: 30889629
Background: Sea cucumber is a kind of nutritious echinoderm that has multiple biological activities, including antioxidant, antibacterial, and antitumor activities. However, there is no extensive study on the antitumor effect...
6.
Ye Z, Huang J, Zhou L, Chen S, Wang Z, Ma L, et al.
Urology . 2019 Mar; 129:172-179. PMID: 30880074
Objective: To evaluate the efficacy and safety of Serenoa repens among patients with benign prostatic hyperplasia (lower urinary tract symptoms/benign prostatic hyperplasia [LUTS/BPH]) in China. Methods: We conducted a double...
7.
Huang B, Wang H, Lin H, Yao Z, Zheng J, Fan W, et al.
J Cancer Res Clin Oncol . 2018 Dec; 145(2):487-494. PMID: 30539282
Objective: Comparing intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone in the treatment of T1-staged Grade 3 (T1G3) bladder cancer after transurethral resection of bladder tumor (TURBT). Materials...
8.
Lin H, Huang B, Wang H, Liu X, Hong Y, Qiu S, et al.
Cell Physiol Biochem . 2018 Nov; 51(2):991-1000. PMID: 30466107
Background/aims: To investigate the role of methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) in the clinical prognosis and cell biology of renal cell carcinoma (RCC). Methods: A total of 137 RCC tissues were...
9.
Wang Z, Xiao H, Wei G, Zhang N, Wei M, Chen Z, et al.
BMC Cancer . 2018 Nov; 18(1):1108. PMID: 30419836
Background: To compare the efficacy of low dose (27 mg) Bacillus Calmette-Guérin (BCG) and a full dose (81 mg) BCG immunotherapy for patients with intermediate and high-risk non-muscle invasive bladder...
10.
Huang B, Zheng J, Yao Z, Fan W, Qiu S, Chen L, et al.
World J Urol . 2018 Sep; 37(5):823-829. PMID: 30191393
Purpose: To assess the efficacy of intra-arterial chemotherapy (IAC) combined with intravesical chemotherapy (IVC) in T1G3 bladder cancer (Bca) after transurethral resection of bladder tumor (TURBT). Methods: Our study retrospectively...